EL7.AI
StocksMedium•12 November 2026•
2 min read

BioHarvest Sets 8:00 a.m. Call to Discuss Third-Quarter Results and Business Update

Key Facts

1The company scheduled its third-quarter results call for November 12, 2026, at 8:00 a.m. Eastern Time.
2Second-quarter 2026 revenue was $8.8 million, up 3.8% year over year.
3The second-quarter 2026 operating loss was $2.5 million, compared with $1.8 million a year earlier.
4The company cut its 2026 VINIA revenue outlook to $33–35 million and its CDMO revenue outlook to $4–5 million.

BioHarvest Sciences scheduled a call and webcast to discuss its third-quarter 2026 results and business update for November 12 at 8:00 a.m. Eastern Time, according to a company announcement. The call comes as the company pursues its strategic shift toward contract development and manufacturing organization (CDMO) services. Chief Executive Zaki Rakib said ahead of the results that he looked forward to discussing progress on the transition and the opportunities the company sees to build a scalable business. He added that the discussion would cover long-term growth and profitability opportunities. This follows the company’s August cut to its annual revenue outlook for VINIA and CDMO services.

In the second quarter of 2026, BioHarvest reported revenue of $8.8 million, up 3.8% year over year, according to its published results. Gross margin was 58%, compared with 59% in the same period a year earlier. The operating loss also widened to $2.5 million from $1.8 million in the second quarter of 2025. The company said at the time that VINIA was a stable and growing business. It said it had prioritized margins and cash discipline over revenue growth driven by higher customer acquisition costs.

In its August guidance, BioHarvest cut its 2026 direct-to-consumer VINIA revenue range to $33–35 million. It also narrowed its expected revenue range for CDMO services to $4–5 million. The adjustment reflects two distinct areas of the company’s business: product sales and contract development and manufacturing services. In a separate disclosure, the company said an agreement to manufacture and supply a rare botanical flavor ingredient targets production of 20 tons. It added that limited production under the agreement could begin in the first half of 2027.

BioHarvest shares, which trade under the ticker BHST, closed at $1.75 in the November 11 session, according to EL7 data. The November 12 call gives the company an opportunity to present its third-quarter results and business update at the start of the scheduled session. Management is expected to discuss progress on the strategic shift and the opportunities it sees to build a scalable business. Rakib had linked the discussion to long-term growth and profitability. The call starts at 8:00 a.m. Eastern Time.

Open on chart